| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Makunje Moses | Title: VP, Finance and principal financial and accounting officer. | C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 03 Mar 2026 | 0002001938 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Award | $0 | +50,761 | +292% | $0.000000 | 68,137 | 27 Feb 2026 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Stock Option (Right to Buy) | Award | $0 | +224,439 | $0.000000 | 224,439 | 27 Feb 2026 | Class A Common Stock | 224,439 | $5.91 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement. 25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date. |
| F2 | Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan. |
| F3 | Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |
Title: VP, Finance and principal financial and accounting officer.